• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白 S 海勒姆突变杂合性与静脉血栓形成风险相关。

Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.

机构信息

Laboratory of Haematology, La Timone Hospital, Marseille, France.

Institut National pour la Santé et la Recherche Médicale (INSERM), Unité Mixte de Recherche en Santé(UMR_S) 1062, Nutrition Obesity and Risk of Thrombosis, Aix-Marseille University, Marseille, France.

出版信息

Sci Rep. 2017 Apr 4;7:45507. doi: 10.1038/srep45507.

DOI:10.1038/srep45507
PMID:28374852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5379621/
Abstract

Hereditary Protein S (PS) deficiency is a rare coagulation disorder associated with an increased risk of venous thrombosis (VT). The PS Heerlen (PSH) mutation is a rare S501P mutation that was initially considered to be a neutral polymorphism. However, it has been later shown that PSH has a reduced half-life in vivo which may explain the association of PSH heterozygosity with mildly reduced levels of plasma free PS (FPS). Whether the risk of VT is increased in PSH carriers remains unknown. We analyzed the association of PSH (rs121918472 A/G) with VT in 4,173 VT patients and 5,970 healthy individuals from four independent case-control studies. Quantitative determination of FPS levels was performed in a subsample of 1257 VT patients. In the investigated populations, the AG genotype was associated with an increased VT risk of 6.57 [4.06-10.64] (p = 1.73 10). In VT patients in whom PS deficiency was excluded, plasma FPS levels were significantly lower in individuals with PSH when compared to those without [72 + 13 vs 91 + 21 UI/dL; p = 1.86 10, mean + SD for PSH carriers (n = 21) or controls (n = 1236) respectively]. We provide strong evidence that the rare PSH variant is associated with VT in unselected individuals.

摘要

遗传性蛋白 S(PS)缺乏症是一种罕见的凝血障碍,与静脉血栓形成(VT)的风险增加有关。PS Heerlen(PSH)突变是一种罕见的 S501P 突变,最初被认为是一种中性多态性。然而,后来的研究表明,PSH 在体内的半衰期较短,这可能解释了 PSH 杂合子与血浆游离 PS(FPS)水平轻度降低的相关性。PSH 携带者的 VT 风险是否增加仍不清楚。我们分析了四个独立病例对照研究中的 4173 名 VT 患者和 5970 名健康个体中 PSH(rs121918472 A/G)与 VT 的相关性。在 1257 名 VT 患者的亚样本中进行了 FPS 水平的定量测定。在所研究的人群中,AG 基因型与 VT 风险增加 6.57 [4.06-10.64](p = 1.73 10)相关。在排除 PS 缺乏的 VT 患者中,与无 PSH 的个体相比,PSH 个体的血浆 FPS 水平显著降低[72 + 13 与 91 + 21 UI/dL;p = 1.86 10,PSH 携带者(n = 21)或对照者(n = 1236)的平均值 + SD]。我们提供了强有力的证据表明,罕见的 PSH 变体与未选择个体中的 VT 相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b7/5379621/14e9333721dd/srep45507-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b7/5379621/14e9333721dd/srep45507-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b7/5379621/14e9333721dd/srep45507-f1.jpg

相似文献

1
Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.蛋白 S 海勒姆突变杂合性与静脉血栓形成风险相关。
Sci Rep. 2017 Apr 4;7:45507. doi: 10.1038/srep45507.
2
PROS1 genotype phenotype relationships in a large cohort of adults with suspicion of inherited quantitative protein S deficiency.PROS1 基因型表型关系在一大群怀疑遗传性定量蛋白 S 缺乏的成年人中。
Thromb Haemost. 2016 Mar;115(3):570-9. doi: 10.1160/TH15-05-0391. Epub 2015 Oct 15.
3
A Case of a Pediatric Patient With Protein S Heerlen Polymorphism and Deep Venous Thrombosis.一例具有蛋白 S 海勒姆多态性的儿科患者合并深静脉血栓形成。
J Pediatr Hematol Oncol. 2022 Mar 1;44(2):e442-e443. doi: 10.1097/MPH.0000000000002299.
4
The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities.重组蛋白S海尔伦中的Ser460Pro突变不影响其作为活化蛋白C辅因子和不依赖活化蛋白C的抗凝活性。
Thromb Haemost. 2004 Jun;91(6):1105-14. doi: 10.1160/TH04-02-0082.
5
Association of protein S p.Pro667Pro dimorphism with plasma protein S levels in normal individuals and patients with inherited protein S deficiency.正常个体及遗传性蛋白S缺乏症患者中蛋白S p.Pro667Pro二态性与血浆蛋白S水平的关联
Thromb Res. 2007;120(3):421-6. doi: 10.1016/j.thromres.2006.10.014. Epub 2006 Dec 15.
6
Genetic and phenotypic variability between families with hereditary protein S deficiency.遗传性蛋白S缺乏症家族之间的遗传和表型变异性。
Thromb Haemost. 2002 Feb;87(2):258-65. doi: 10.1055/s-0037-1612982.
7
Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population.对蛋白 C 缺乏症的遗传背景分析显示,在中国人群中与静脉血栓形成相关的一种反复出现的突变。
PLoS One. 2012;7(4):e35773. doi: 10.1371/journal.pone.0035773. Epub 2012 Apr 24.
8
[Recurrent deep vein thrombosis caused by heterozygous missense mutation of the protein S gene: genetic analysis of a case].[蛋白S基因杂合错义突变导致复发性深静脉血栓形成:1例病例的基因分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2011 Jun;31(7):1228-31.
9
Heerlen polymorphism associated with type III protein S deficiency and factor V Leiden mutation in a Polish patient with deep vein thrombosis.一名患有深静脉血栓形成的波兰患者中与III型蛋白S缺乏症和因子V莱顿突变相关的海尔伦多态性。
Blood Coagul Fibrinolysis. 2014 Jan;25(1):84-5. doi: 10.1097/MBC.0b013e328365032c.
10
Genetic variants in Cell Adhesion Molecule 1 (CADM1): a validation study of a novel endothelial cell venous thrombosis risk factor.细胞粘附分子1(CADM1)中的基因变异:一种新型内皮细胞静脉血栓形成危险因素的验证研究
Thromb Res. 2014 Dec;134(6):1186-92. doi: 10.1016/j.thromres.2014.09.018. Epub 2014 Sep 23.

引用本文的文献

1
Inherited Thrombophilia in the Era of Direct Oral Anticoagulants.直接口服抗凝剂时代的遗传性血栓形成倾向。
Int J Mol Sci. 2022 Feb 5;23(3):1821. doi: 10.3390/ijms23031821.
2
A pilot study on the impact of congenital thrombophilia in COVID-19.一项关于先天性血栓形成倾向对新型冠状病毒肺炎影响的初步研究。
Eur J Clin Invest. 2021 May;51(5):e13546. doi: 10.1111/eci.13546. Epub 2021 Mar 25.
3
A rare coding mutation in the MAST2 gene causes venous thrombosis in a French family with unexplained thrombophilia: The Breizh MAST2 Arg89Gln variant.

本文引用的文献

1
Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis.对6135名个体和252827名对照者自我报告事件进行的全基因组关联分析确定了8个与血栓形成相关的基因座。
Hum Mol Genet. 2016 May 1;25(9):1867-74. doi: 10.1093/hmg/ddw037. Epub 2016 Feb 9.
2
Contribution of Rare and Common Genetic Variants to Plasma Lipid Levels and Carotid Stiffness and Geometry: A Substudy of the Paris Prospective Study 3.罕见和常见基因变异对血浆脂质水平、颈动脉僵硬度及几何形态的影响:巴黎前瞻性研究3的一项子研究
Circ Cardiovasc Genet. 2015 Aug;8(4):628-36. doi: 10.1161/CIRCGENETICS.114.000979. Epub 2015 Jul 9.
3
一个罕见的 MAST2 基因突变导致一个法国家族性不明原因血栓形成伴静脉血栓形成:Breizh MAST2 Arg89Gln 变异体。
PLoS Genet. 2021 Jan 19;17(1):e1009284. doi: 10.1371/journal.pgen.1009284. eCollection 2021 Jan.
4
Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation.只有在不携带因子 V Leiden 突变的情况下,因子 V K858R 变异的次要等位基因才能保护免受静脉血栓形成。
Sci Rep. 2019 Mar 6;9(1):3750. doi: 10.1038/s41598-019-40172-x.
5
A large-scale exome array analysis of venous thromboembolism.一项关于静脉血栓栓塞的大规模外显子组芯片分析。
Genet Epidemiol. 2019 Jun;43(4):449-457. doi: 10.1002/gepi.22187. Epub 2019 Jan 19.
Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF.
罕见和低频变异及其与纤维蛋白原、FVII、FVIII和vWF血浆水平的关联。
Blood. 2015 Sep 10;126(11):e19-29. doi: 10.1182/blood-2015-02-624551. Epub 2015 Jun 23.
4
Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.对65734名个体进行的荟萃分析确定TSPAN15和SLC44A2为静脉血栓栓塞的两个易感基因座。
Am J Hum Genet. 2015 Apr 2;96(4):532-42. doi: 10.1016/j.ajhg.2015.01.019. Epub 2015 Mar 12.
5
TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.蛋白S的组织因子途径抑制物(TFPI)辅因子功能:蛋白S性激素结合球蛋白样结构域的关键作用。
Blood. 2014 Jun 19;123(25):3979-87. doi: 10.1182/blood-2014-01-551812. Epub 2014 Apr 16.
6
Heerlen polymorphism associated with type III protein S deficiency and factor V Leiden mutation in a Polish patient with deep vein thrombosis.一名患有深静脉血栓形成的波兰患者中与III型蛋白S缺乏症和因子V莱顿突变相关的海尔伦多态性。
Blood Coagul Fibrinolysis. 2014 Jan;25(1):84-5. doi: 10.1097/MBC.0b013e328365032c.
7
Protein S levels and the risk of venous thrombosis: results from the MEGA case-control study.蛋白 S 水平与静脉血栓栓塞风险:来自 MEGA 病例对照研究的结果。
Blood. 2013 Oct 31;122(18):3210-9. doi: 10.1182/blood-2013-04-499335. Epub 2013 Sep 6.
8
C4b-binding protein: a forgotten factor in thrombosis and hemostasis.C4b 结合蛋白:血栓形成和止血中的一个被遗忘的因素。
Semin Thromb Hemost. 2011 Jun;37(4):355-61. doi: 10.1055/s-0031-1276584. Epub 2011 Jul 30.
9
Protein S inherited qualitative deficiency: novel mutations and phenotypic influence.蛋白 S 遗传性质量缺陷:新型突变及表型影响。
J Thromb Haemost. 2010 Dec;8(12):2718-26. doi: 10.1111/j.1538-7836.2010.04073.x.
10
Finding the missing heritability of complex diseases.寻找复杂疾病中缺失的遗传力。
Nature. 2009 Oct 8;461(7265):747-53. doi: 10.1038/nature08494.